Abstract
Many retroviral oncogenes have been classified into one of several categories based on structure, enzymology and cellular localization1. These genes originated from host cells and are probably derived from genes normally involved in the control of cell proliferation2. The cellular counterparts of three oncogenes have been identified as a growth factor or growth factor receptor3–6; related oncogenes include receptor-like membrane proteins which often express tyrosine kinase activity. These growth factor-related oncogenes are structurally and biochemically distinct from the membrane-associated ras gene family, which bind and hydrolyse GTP7–9. Oncogenes localized primarily in the cytoplasm which probably have serine kinase activity, have also been identified10–12. Although the structure and biochemistry of many oncogenes have been extensively studied, relatively little is known about the functional relationships of oncogene proteins within the cell. An opportunity to study such interaction is provided by the identification of a monoclonal antibody that neutralizes cellular ras proteins when microinjected into cells13. It has been shown previously that the injected antibody inhibits the initiation of S-phase in NIH 3T3 cells14. In the present study we injected this monoclonal antibody into NIH 3T3 cells transformed by a variety of oncogenes. The results show that transformation by three growth factor receptor-like oncogenes depends on c-ras proteins, while transformation by two cytoplasmic oncogenes appears to be independent of c-ras protein.
Similar content being viewed by others
Article PDF
References
Bishop, J. M. Cell 42, 23–38 (1985).
Bishop, J. M. & Varmus, H. E. in RNA Tumor Viruses: Molecular Biology of Tumor Viruses 2nd end (eds Weiss, R., Teich, M., Varmus, H. & Coffin, J.) 999–1108 (Cold Spring Harbor Laboratory, New York, 1984).
Doolittle, F. R. et al. Science 221, 275–277 (1983).
Downward, J. et al. Nature 307, 521–527 (1984).
Waterfield, M. D. et al. Nature 304, 35–39 (1983).
Sherr, C. J. et al. Cell 41, 665–676 (1985).
Ellis, R. W. et al. Nature 292, 506–511 (1981).
Sweet, R. W. et al. Nature 311, 273–275 (1984).
McGrath, J. P., Capon, D. J., Goeddel, D. V. & Levinson, A. D. Nature 310,644–649 (1984).
Kloetzer, W. S., Maxwell, S. A. & Arlinghaus, R. B. Virology 138, 143–155 (1984).
Moelling, K., Heimann, B., Beimling, P., Rapp, U. R. & Sander, T. Nature 312, 558–561 (1984).
Papkoff, J., Nigg, E. A. & Hunter, T. Cell 33, 161–172 (1983).
Kung, H.-F., Smith, M. R., Bekesi, E., Manne, V. & Stacey, D. W. Expl Cell Res. 162, 363–371 (1986).
Mulcahy, L. S., Smith, M. R. & Stacey, D. W. Nature 313, 241–243 (1985).
Furth, M. E., Davis, L. J., Fleurdelys, B. & Scolnick, E. M. J. Virol. 43, 294–304 (1982).
Stacey, D. W., DeGudicibus, S. J. & Smith, M. R. (in preparation).
Brugge, J. S. & Erikson, R. L. Nature 269, 346–348 (1977).
Fedele, L. A., Even, J., Garon, C. F., Donner, L. & Sherr, C. J. Proc. natn. Acad. Sci. U.S.A. 78, 4036–4040 (1981).
Donner, L., Fedele, L. A., Garon, C. F., Anderson, S. J. & Sherr, C. J. J. Virol. 41, 489–500 (1982).
Robbins, K. C., Devare, S. G., Reddy, E. P. & Aaronson, S. A. Science 218, 1131–1133 (1982).
Blair, D. G., McClements, W. L., Oskarsson, M. K., Fischinger, P. J. & Vande Woude, G.F. Proc. natn. Acad. Sci. U.S.A. 77, 3504–3508 (1980).
Rapp, U. R. & Todaro, G. J. Proc. natn. Acad. Sci. U.S.A. 77, 624–628 (1980).
Horn, J. R., Wood, T. G., Murphy, E. C., Blair, D. G. & Arlinghaus, R. B. Cell 25, 37–46 (1981).
Noda, M., Selinger, Z., Scolnick, E. M. & Bassin, R. H. Proc. natn. Acad. Sci. U.S.A. 80, 5602–5606 (1983).
Schiller, J. T., Vass, W. C. & Lowy, D. R. Proc. natn. Acad. Sci. U.S.A. 81,7880–7884 (1984).
Papageorge, A. G. et al. Molec. cell Biol. (in the press).
Beckner, S. K., Hattori, S. & Shih, T Y. Nature 317, 71–72 (1985).
Gilman, A. Cell 36, 577–579 (1984).
Wigler, M. et al. Proc. natn. Acad. Sci. U.S.A. 76, 1373–1376 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, M., DeGudicibus, S. & Stacey, D. Requirement for c-ras proteins during viral oncogene transformation. Nature 320, 540–543 (1986). https://doi.org/10.1038/320540a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/320540a0
This article is cited by
-
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1
International Journal of Clinical Oncology (2024)
-
Ubiquitin-specific protease 28: the decipherment of its dual roles in cancer development
Experimental Hematology & Oncology (2023)
-
Molecular processes involved in B cell acute lymphoblastic leukaemia
Cellular and Molecular Life Sciences (2018)
-
Regulation of RAF protein kinases in ERK signalling
Nature Reviews Molecular Cell Biology (2015)
-
Src kinase function controls progenitor cell pools during regeneration and tumor onset in the Drosophila intestine
Oncogene (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.